Premium
Doping control analysis at the Rio 2016 Olympic and Paralympic Games
Author(s) -
Pereira Henrique Marcelo Gualberto,
Sardela Vinicius Figueiredo,
Padilha Monica Costa,
Mirotti Luciana,
Casilli Alessandro,
Oliveira Fabio Azamor,
Albuquerque Cavalcanti Gustavo,
Rodrigues Lucas Martins Lisandro,
Araujo Amanda Lessa Dutra,
Levy Rachel Santos,
Teixeira Pedro Antonio Castelo,
Oliveira Felipe Alves Gomes,
Duarte Ana Carolina Giordani,
Carneiro Ana Carolina Dudenhoeffer,
Evaristo Joseph Albert Medeiros,
Santos Gustavo Ramalho Cardoso,
Costa Giovanni Carlo Verissimo,
Lima Castro Fernando,
Nogueira Fabio Cesar Sousa,
Scalco Fernanda Bertão,
Pizzatti Luciana,
Aquino Neto Francisco Radler
Publication year - 2017
Publication title -
drug testing and analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 54
eISSN - 1942-7611
pISSN - 1942-7603
DOI - 10.1002/dta.2329
Subject(s) - agency (philosophy) , disease control , control (management) , medicine , environmental health , sociology , management , economics , social science
This paper summarises the results obtained from the doping control analyses performed during the Summer XXXI Olympic Games (August 3–21, 2016) and the XV Paralympic Games (September 7–18, 2016). The analyses of all doping control samples were performed at the Brazilian Doping Control Laboratory (LBCD), a World Anti‐Doping Agency (WADA)‐accredited laboratory located in Rio de Janeiro, Brazil. A new facility at Rio de Janeiro Federal University (UFRJ) was built and fully operated by over 700 professionals, including Brazilian and international scientists, administrative staff, and volunteers. For the Olympic Games, 4913 samples were analysed. In 29 specimens, the presence of a prohibited substance was confirmed, resulting in adverse analytical findings (AAFs). For the Paralympic Games, 1687 samples were analysed, 12 of which were reported as AAFs. For both events, 82.8% of the samples were urine, and 17.2% were blood samples. In total, more than 31 000 analytical procedures were conducted. New WADA technical documents were fully implemented; consequently, state‐of‐the‐art analytical toxicology instrumentation and strategies were applied during the Games, including different types of mass spectrometry (MS) analysers, peptide, and protein detection strategies, endogenous steroid profile measurements, and blood analysis. This enormous investment yielded one of the largest Olympic legacies in Brazil and South America. Copyright © 2017 John Wiley & Sons, Ltd.